FRNM ▲ +3.7% - Freenome, Inc. $FRNM -- Guggenheim mentions Carelon Healthcare Services (ELV) just updated Clinical Guideline reimbursements To Include Freenome’s SimpleScreen - (SM Circulations) Freenome rose 3.7% after Guggenheim reported that Carelon Healthcare Services updated its clinical reimbursement guidelines to include Freenome's SimpleScreen test. The coverage expansion signals a meaningful step toward mainstream adoption of the company's blood-based cancer screening product. 01-SEP-2026 11:50 AM ET